DC Field | Value | Language |
---|---|---|
dc.contributor.advisor | Lee, Doheon | - |
dc.contributor.advisor | 이도헌 | - |
dc.contributor.author | Yim, Soorin | - |
dc.date.accessioned | 2023-06-21T19:34:20Z | - |
dc.date.available | 2023-06-21T19:34:20Z | - |
dc.date.issued | 2022 | - |
dc.identifier.uri | http://library.kaist.ac.kr/search/detail/view.do?bibCtrlNo=1007796&flag=dissertation | en_US |
dc.identifier.uri | http://hdl.handle.net/10203/308039 | - |
dc.description | 학위논문(박사) - 한국과학기술원 : 바이오및뇌공학과, 2022.8,[iv, 60 p. :] | - |
dc.description.abstract | Cancer is one of the leading causes of human death, requiring novel therapeutics for the treatment. Despite continuous efforts to conquer cancer, many clinical trials still fail due to efficacy and side effect issues. To reduce the time and costs of the development of anti-cancer drugs, we developed two approaches to the data-driven identification and validation of therapeutic targets for cancer. We introduced intercellular CRISPR screen, which combines two genome-wide CRISPR screen datasets, each in cancer and immune cells, to identify regulators of immune cell function. Our results showed that intercellular CRISPR screens can identify well-known modulators of cytotoxic T cells and suggested seven novel intercellular interactions as the potential targets of immunotherapy. To validate targets for targeted therapy, we developed GESIGAN, a generative adversarial network model for predicting context-specific gene expression signatures upon gene knockouts. We used the predicted gene expression signatures for the validation of cancer therapeutic targets via reversal of cancer gene expression signatures. We envision that data-driven approaches to drug discovery will help to reduce the time and cost required for the development of novel cancer therapeutics. | - |
dc.language | eng | - |
dc.publisher | 한국과학기술원 | - |
dc.subject | Drug discovery▼aTarget discovery▼aImmunotherapy▼aCRISPR-Cas9▼aArtificial intelligence▼aDeep learning | - |
dc.subject | 신약개발▼a타겟 발굴▼a면역항암제▼aCRISPR-Cas9▼a인공지능▼a딥러닝 | - |
dc.title | Data-driven target discovery and validation for cancer therapy | - |
dc.title.alternative | 데이타 기반 항암제 타겟 발굴 및 검증 | - |
dc.type | Thesis(Ph.D) | - |
dc.identifier.CNRN | 325007 | - |
dc.description.department | 한국과학기술원 :바이오및뇌공학과, | - |
dc.contributor.alternativeauthor | 임수린 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.